This inventor holds 6 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Amgen Inc., Amgen Sf, LLC. Active years: 2007-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2011
Title: Innovator Spotlight: Philippe Bergeron - Pioneering Treatments for Inflammatory Disorders
Introduction: Philippe Bergeron, a prolific inventor based in San Mateo, CA, has made significant contributions to the field of pharmaceuticals with his innovative patents focused on treating inflammatory and immunoregulatory disorders and diseases. His relentless pursuit of novel compounds and treatment methods has garnered him recognition in the scientific community.
Latest Patents: Bergeron's latest patents showcase his groundbreaking work in developing compounds, compositions, and methods for the prevention and treatment of inflammatory and immunoregulatory disorders. One of his patents involves compounds useful for treating conditions such as multiple sclerosis, rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Another patent focuses on bisaryl-sulfonamides for treating conditions mediated by PPARγ or PPARδ, such as diabetes, obesity, hypercholesterolemia, rheumatoid arthritis, and atherosclerosis.
Career Highlights: Philippe Bergeron is currently affiliated with Amgen San Francisco, LLC, a prominent biotechnology company at the forefront of developing innovative therapies. His work at Amgen has been instrumental in advancing the company's research and development efforts in the field of inflammatory disorders and immune conditions. Bergeron's expertise has been pivotal in driving forward cutting-edge treatments for complex diseases.
Collaborations: Throughout his career, Philippe Bergeron has collaborated closely with esteemed colleagues such as Julio Cesar Medina and Xiaoqi Chen. Together, they have synergized their knowledge and expertise to generate impactful solutions for challenging medical conditions. Their collaborative efforts have led to the successful development of transformative therapies that have the potential to improve patient outcomes worldwide.
Conclusion: In conclusion, Philippe Bergeron stands out as a visionary inventor with a remarkable ability to innovate in the realm of pharmaceuticals. His dedication to pioneering new treatments for inflammatory disorders and diseases underscores his commitment to advancing healthcare solutions. With a robust portfolio of patents and a track record of successful collaborations, Bergeron continues to make a lasting impact on the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile